Xiaoli Bi

机构：Guangdong Provincial Hospital of Traditional Chinese Medicine, Traditional Chinese Medicine Bureau of Guangdong Province · ORCID：0000-0002-8800-4705

发表论文 42 篇 · 总被引 270 次 · h-index 11

代表论文

• ESL attenuates BLM-induced IPF in mice: Dual mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a pathways (2024 · Phytomedicine · 被引 22)
• Comparison of ELSD and RID combined with HPLC for simultaneous determination of six rare sugars in food components (2024 · Microchemical Journal · 被引 19)
• Network pharmacology analysis and experimental validation to explore the mechanism of Bushao Tiaozhi capsule (BSTZC) on hyperlipidemia (2022 · Scientific Reports · 被引 19)
• Integrating network toxicology and molecular docking to explore the toxicity of the environmental pollutant butyl hydroxyanisole: An example of induction of chronic urticaria (2024 · Heliyon · 被引 18)
• A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin (2023 · Heliyon · 被引 18)
• Investigation into the anti-inflammatory mechanism of Pothos chinensis (Raf.) Merr. By regulating TLR4/MyD88/NF-κB pathway: Integrated network pharmacology, serum pharmacochemistry, and metabolomics (2024 · Journal of Ethnopharmacology · 被引 17)